Aaron Grossberg

Aaron Grossberg, M.D., Ph.D., serves as Associate Professor of Radiation Medicine at Oregon Health & Science University (OHSU) School of Medicine, with joint appointments at the Cancer Early Detection Advanced Research Center and Brenden-Colson Center for Pancreatic Care. His clinical practice specializes in pancreatic and breast cancers, utilizing stereotactic body radiation therapy (SBRT) and hypofractionated radiation techniques for both early and locally-advanced pancreatic malignancies.

Dr. Grossberg's educational background includes:

• B.A. (2002) from University of Colorado Boulder
• Ph.D. (2011) and M.D. (2013) from Oregon Health & Science University
• Internal Medicine Internship (2014) at Providence St. Vincent Medical Center
• Radiation Oncology Residency (2018) at MD Anderson Cancer Center

His research program investigates the metabolic interactions between cancer and host physiology to improve early detection and patient quality of life. Key focuses include genetic and molecular determinants of radiation therapy toxicities, biomarker discovery for pancreatic cancer, and advanced radiation techniques. Current projects involve cell-free RNA diagnostics, cachexia mechanisms, and sarcopenia quantification in cancer patients.

Analysis of his 15 most recent publications (2022-2025) reveals strong emphasis on pancreatic cancer early detection (47% of articles), metabolic interactions (27%), and radiation therapy optimization (13%). Recurring themes include biomarker validation (GDF15, LCN2), health disparities research, and sarcopenia quantification methods using AI-enhanced imaging.

No specific scientific awards or prizes were listed in the source materials, though Dr. Grossberg maintains active membership in major professional societies.

Information regarding student advising and grant funding specifics was not provided in the available text.

Dr. Grossberg conducts research through OHSU's Cancer Early Detection Advanced Research Center and Brenden-Colson Center for Pancreatic Care, with clinical practice at OHSU Knight Cancer Institute locations in Beaverton and Portland.